Previous Article | Next Article ![]()
Infection and Immunity, February 1999, p. 630-635, Vol. 67, No. 2
Department of Clinical Investigation, Texas
Center for Infectious Disease, San Antonio, Texas 78223
Received 8 September 1998/Returned for modification 6 October
1998/Accepted 3 November 1998
Previous studies from our laboratory established that C-ASWS, an
alkali-soluble, water-soluble extract from cell walls of Coccidioides immitis, protects mice against lethal
challenge with this fungus. The C-ASWS extract contains a glycosylated
protein, designated antigen 2 (Ag2), and a polysaccharide antigen. We
recently cloned Ag2 cDNA and showed that the recombinant fusion protein elicited strong delayed-type hypersensitivity responses in immunized mice. This investigation was undertaken to determine if the recombinant Ag2 protein, expressed as an Ag2-glutathione S-transferase
(GST) fusion protein, or Ag2 cDNA would protect mice against lethal challenge with C. immitis. The recombinant Ag2-GST protein
protected BALB/c mice against intraperitoneal challenge with 250 arthroconidia, as assessed by a decrease in fungal CFU in tissues. The
Ag2-GST-immunized mice did not show, however, an increased survival
during a 30-day period postinfection. By contrast, immunization of mice
with Ag2 cDNA ligated into the pVR1012 plasmid engendered protection
against intraperitoneal challenge with 2,500 arthroconidia and against pulmonary challenge with 50 arthroconidia. Vaccine efficacy paralleled the development of delayed-type hypersensitivity responses to C. immitis antigen. Whereas mice vaccinated with the recombinant Ag2-GST protein did not mount footpad hypersensitivity to C-ASWS or the
recombinant Ag2-GST protein, mice vaccinated with the pVR1012-Ag2 construct mounted a strong footpad hypersensitivity and their spleen
cells secreted gamma interferon upon in vitro stimulation with the
Ag2-containing C-ASWS extract. This is the first investigation to show
that genetic immunization can protect against lethal challenge with
C. immitis.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Genetic Vaccination against Coccidioides
immitis: Comparison of Vaccine Efficacy of Recombinant Antigen 2 and Antigen 2 cDNA
*
Corresponding author. Mailing address: Department of
Clinical Investigation, Texas Center for Infectious Disease, 2303 SE Military Dr., San Antonio, TX 78223. Phone: (210) 534-8857, ext. 2458. Fax: (210) 531-4550. E-mail:
rebecca.cox{at}tdh.state.tx.us.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»